(410 ILCS 245/1) (from Ch. 111 1/2, par. 5701) (Section scheduled to be repealed on January 1, 2025) Sec. 1. Title. This Act shall be known and may be cited as the "Reye's
Syndrome Reporting Act". (Source: P.A. 82-501. Repealed by P.A. 103-1043, eff. 1-1-25.) |
(410 ILCS 245/2) (from Ch. 111 1/2, par. 5702) (Section scheduled to be repealed on January 1, 2025) Sec. 2. Definitions. As used in this Act: (a) "Department" means the Illinois Department of Public Health. (b) "Director" means the Director of the Illinois Department of Public Health. (c) "Facility" means a governmental or private agency, department, institution,
clinic, laboratory, hospital, or a health maintenance organization, association,
or other similar unit designated by the Director. (Source: P.A. 82-501. Repealed by P.A. 103-1043, eff. 1-1-25.) |
(410 ILCS 245/3) (from Ch. 111 1/2, par. 5703) (Section scheduled to be repealed on January 1, 2025) Sec. 3. Reporting Reye's Syndrome. An attending physician or other person
representing or employed by a facility as determined by the Director shall
report the existence of Reye's Syndrome when the physician or person determined
by the Director diagnoses or confirms the presence of that illness. (Source: P.A. 82-501. Repealed by P.A. 103-1043, eff. 1-1-25.) |
(410 ILCS 245/4) (from Ch. 111 1/2, par. 5704) (Section scheduled to be repealed on January 1, 2025) Sec. 4. Report; contents, filing, availability for research and public inspection. (1) The report prescribed in Section 3 shall be designated a Reye's Syndrome
report and shall contain information which the Director considers necessary
to identify, locate, and investigate the occurrence, frequency, incidence,
cause, effect, and prognosis of Reye's Syndrome, and other relevant data
and findings with respect thereto. (2) The Director shall promulgate rules regarding the form, content, and
manner of filing the report prescribed in Section 3, which shall be submitted
to the department unless otherwise prescribed by the Director. Any such
rules promulgated by the Director shall contain a specific provision guaranteeing
the maintenance of the physician-patient privilege. (3) A report or other data relating to Reye's Syndrome which discloses
the identity of an individual who was reported as having Reye's Syndrome
shall be made available only to persons who demonstrate a need for the report
or other data which is essential to health related research. No report or
data or portion of such data which discloses the identity of the individual
shall be made available to the public. (4) Nothing in this Section shall mandate the Department to investigate
or otherwise follow-up any reported incidence of Reye's Syndrome. (Source: P.A. 82-501. Repealed by P.A. 103-1043, eff. 1-1-25.) |
(410 ILCS 245/5) (from Ch. 111 1/2, par. 5705) (Section scheduled to be repealed on January 1, 2025) Sec. 5. Maintenance of reports. Reye's Syndrome reports and data shall be maintained by the department in a manner suitable for use for research purposes, and shall be made available to persons as prescribed in Section 4. (Source: P.A. 82-501. Repealed by P.A. 103-1043, eff. 1-1-25.) |
(410 ILCS 245/6) (from Ch. 111 1/2, par. 5706) (Section scheduled to be repealed on January 1, 2025) Sec. 6. Implementation of Act; rules. The Director shall promulgate
rules to implement this Act which foster the study, research, diminution,
and control of Reye's Syndrome in this State. (Source: P.A. 82-501. Repealed by P.A. 103-1043, eff. 1-1-25.) |